Canada is a world leader in biotechnology with internationally-renowned scientists ranking 2nd in terms of the number of biotechnology companies, with approximately 470 companies; 3rd in biotechnology revenues; 3rd in R&D spending by the private sector; and 5th for the number of biotechnology inventions.

Over 50% of companies are in the health sector with strengths in cancer therapy, cardiovascular therapy, human vaccines, drug delivery systems, contract research and diagnostics.

Canada’s R&D environment ranks 1st in terms of cost competitiveness for biomedical R&D compared to other industrialized nations, including the United States, Europe and Japan. Biotechnology companies in the agriculture sector have unique strengths in canola and corn production, as well as in increasing productivity and the development of new products. Canada has a first-rate science base and business environment, and a proven entrepreneurial approach that emphasizes clusters and partnerships.

In addition, Canada has a strong financing and venture capital base for the industry. Canada has a number of world-renowned clusters of biotechnology excellence, resulting in the development of successful, knowledge-intensive firms out of universities, research institutions and government laboratories.

Upcoming Business Missions: Read more